Pharmamarketeer

J&J, U.S. states settle hip implant claims for $120 million

Johnson & Johnson and its DePuy Orthopaedics unit have agreed to pay $120 million to resolve deceptive marketing claims by several U.S. states over the company’s metal-on-metal hip implants.

Medhc-fases-banner
Advertentie(s)